Neurosciences Victoria Ltd Company Profile

04:55 EDT 19th September 2018 | BioPortfolio

NSV® was formed in 2001 to facilitate technology transfer and inward investment into the vibrant and expanding Melbourne neuroscience cluster.NSV provides a "one-stop-shop" for current and potential investors in Australian neuroscience R & D. Through the creation of relationships with biotechnology and pharmaceutical companies, NSV Ltd aims to facilitate new product development for the diagnosis, prevention and treatment of neurological and psychiatric conditions.Through NSV's unified IP management policy, investors can access infrastructure and expertise across a number of institutes and locations, allowing research projects to fully capitalise on complementary strengths across the Melbourne neuroscience cluster. NSV also provides a commercial interface and experienced management team, enhancing investor interactions.


Level 2, 161 Barry Street
Carlton South
VIC 3053


Phone: 61 (0)3 8344 1802
Fax: 61 (0)3 9348 1764

News Articles [105 Associated News Articles listed on BioPortfolio]

Minerva Neurosciences, Inc: Minerva Neurosciences Announces Findings Showing Effect of Roluperidone on Brain-Derived Neurotrophic Factor (BDNF)

WALTHAM, Mass., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nerv...

Minerva Neurosciences, Inc: Minerva Neurosciences Reports Second Quarter 2018 Financial Results and Business Updates

Five ongoing late-stage trials on track for data readouts in 2019WALTHAM, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical com...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Report Second Quarter 2018 Financial Results and Business Updates on August 2, 2018

Management to host conference call WALTHAM, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the developmen...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018

Management to host conference call WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the developme...

Flesh eating ulcer cases on the rise in Victoria

Recent reports have shown a rise in cases of flesh eating ulcers in and around Victoria, Australia. Health experts have said that this could become a serious problem if not handled carefully. They hav...

Magnolia Neurosciences Launches with $31 Million

Magnolia Neurosciences Corporation, co-founded by Accelerator Life Science Partners and The University of Texas MD Anderson Cancer Center, launched with a $31 million Series A financing.

AEVIS VICTORIA SA sold its stake in BioTelemetry, thus realising a total capital gain of CHF 14.3 million on its investment in LifeWatch

AEVIS VICTORIA SA / Key word(s): Disposal 08-Jun-2018 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announce...

Victoria Dockside Sets Benchmark with Office Concept and Record-breaking Rental

Created by Founder of K11 and Executive Vice-Chairman and General Manager of New World Development Adrian Cheng, Victoria Dockside is one of the biggest redevelopment Read more...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Myobloc [Solstice Neurosciences, LLC]

Myobloc (rimabotulinumtoxinB) Injection

PubMed Articles [117 Associated PubMed Articles listed on BioPortfolio]

Surviving neoliberalism, maintaining values: Community health mergers in Victoria, Australia.

Independent, not-for-profit community health services in the state of Victoria, Australia, provide one of that country's few models of comprehensive primary health care (PHC). Recent amalgamations amo...

Genetic characterization of influenza B virus in Cameroon and high frequency of reassortant strains.

Influenza B is broadly divided into B/Victoria and B/Yamagata lineages based on their genetic and antigenic properties. We describe in this study the first report on genome characterization of type B ...

Understanding the profile of Personal Alert Victoria clients who fall.

Personal response systems are used to support frail, older people, and people with disabilities to live independently in their own homes. This paper describes the patterns, characteristics, and outcom...

Diet and hygiene practices influence morbidity in schoolchildren living in Schistosomiasis endemic areas along Lake Victoria in Kenya and Tanzania-A cross-sectional study.

Since 2011, cohorts of schoolchildren in regions bordering Lake Victoria in Kenya and Tanzania have been investigated for morbidity caused by Schistosoma mansoni infection. Despite being neighbouring ...

Artwork Description.

Clinical Trials [29 Associated Clinical Trials listed on BioPortfolio]

The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda

The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communiti...

TIV Infant/Toddler Response Evaluation - Follow-up for Influenza B Boost

Each winter, viruses belonging to two kinds of influenza A ("A/H1N1" & "A/H3N2") and two kinds of influenza B ("B/Yamagata" & "B/Victoria") can cause illness. The yearly influenza vaccine ...

Enhancing Social Interaction With an AlterEgo Artificial Agent

The objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients suffering fr...

Neurosciences-Intensive Care Unit Electrical Stimulation

Patients admitted to the Neurosciences Intensive Care Unit (NSICU) are at particular risk of developing ICU-associated weakness and myopathy, given the unique risks of early mobilization i...

A Study to Evaluate the Immunogenicity of MEDI3250 in Adults 18 to 49 Years of Age

The objective of this study is to prove that MEDI3250 is at least as effective as two different forms the vaccine, FluMist, by comparing the specific events after dosage.

Companies [82 Associated Companies listed on BioPortfolio]

Invest Victoria

Invest Victoria is the investment promotion agency of the State Government of Victoria, Australia. Invest Victoria provides a single entry point to a range of business and investment services for comp...

Merz Neurosciences

Merz Neurosciences is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosci...

National Neuroscience Facility

The National Neuroscience Facility (NNF) was created as a result of Major National Research Facility (MNRF) and Science, Technology and Innovation (STI) grants of $18 million and $4.5 million from the...


LV= is a registered trade mark of Liverpool Victoria Friendly Society Limited (LVFS) and a trading style of the Liverpool Victoria group of companies. LV= offer a range of insurance products including...

Neurosciences Victoria Ltd

NSV® was formed in 2001 to facilitate technology transfer and inward investment into the vibrant and expanding Melbourne neuroscience cluster.NSV provides a "one-stop-shop" for current and potential ...

More Information about "Neurosciences Victoria Ltd" on BioPortfolio

We have published hundreds of Neurosciences Victoria Ltd news stories on BioPortfolio along with dozens of Neurosciences Victoria Ltd Clinical Trials and PubMed Articles about Neurosciences Victoria Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neurosciences Victoria Ltd Companies in our database. You can also find out about relevant Neurosciences Victoria Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Corporate Database Quicklinks

Searches Linking to this Company Record